FDA Inspection 1035437 — Curia New York, Inc.

Curia New York, Inc. — FEI 1310298

The FDA completed an inspection of Curia New York, Inc. on November 9, 2017 in Rensselaer, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 9, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rensselaer, NY (United States)